Proximity-dependent mapping of the HCMV US28 interactome identifies RhoGEF signaling as a requirement for efficient viral reactivation.


Journal

PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921

Informations de publication

Date de publication:
10 2023
Historique:
received: 03 01 2023
accepted: 12 09 2023
revised: 12 10 2023
medline: 23 10 2023
pubmed: 2 10 2023
entrez: 2 10 2023
Statut: epublish

Résumé

Human cytomegalovirus (HCMV) encodes multiple putative G protein-coupled receptors (GPCRs). US28 functions as a viral chemokine receptor and is expressed during both latent and lytic phases of virus infection. US28 actively promotes cellular migration, transformation, and plays a major role in mediating viral latency and reactivation; however, knowledge about the interaction partners involved in these processes is still incomplete. Herein, we utilized a proximity-dependent biotinylating enzyme (TurboID) to characterize the US28 interactome when expressed in isolation, and during both latent (CD34+ hematopoietic progenitor cells) and lytic (fibroblasts) HCMV infection. Our analyses indicate that the US28 signalosome converges with RhoA and EGFR signal transduction pathways, sharing multiple mediators that are major actors in processes such as cellular proliferation and differentiation. Integral members of the US28 signaling complex were validated in functional assays by immunoblot and small-molecule inhibitors. Importantly, we identified RhoGEFs as key US28 signaling intermediaries. In vitro latency and reactivation assays utilizing primary CD34+ hematopoietic progenitor cells (HPCs) treated with the small-molecule inhibitors Rhosin or Y16 indicated that US28 -RhoGEF interactions are required for efficient viral reactivation. These findings were recapitulated in vivo using a humanized mouse model where inhibition of RhoGEFs resulted in a failure of the virus to reactivate. Together, our data identifies multiple new proteins in the US28 interactome that play major roles in viral latency and reactivation, highlights the utility of proximity-sensor labeling to characterize protein interactomes, and provides insight into targets for the development of novel anti-HCMV therapeutics.

Identifiants

pubmed: 37782657
doi: 10.1371/journal.ppat.1011682
pii: PPATHOGENS-D-22-02225
pmc: PMC10569644
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1011682

Subventions

Organisme : NIAID NIH HHS
ID : P01 AI127335
Pays : United States

Informations de copyright

Copyright: © 2023 Medica et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Am J Pathol. 1998 Aug;153(2):481-90
pubmed: 9708808
J Biol Chem. 1994 Nov 18;269(46):28539-42
pubmed: 7961796
Blood. 1995 Dec 1;86(11):4086-90
pubmed: 7492764
FEBS Lett. 1998 Dec 18;441(2):209-14
pubmed: 9883886
Nat Methods. 2013 Aug;10(8):730-6
pubmed: 23921808
Nucleic Acids Res. 2021 Jan 8;49(D1):D605-D612
pubmed: 33237311
Nat Methods. 2006 Feb;3(2):135-9
pubmed: 16432524
PLoS One. 2018 Jul 25;13(7):e0200267
pubmed: 30044826
PLoS One. 2012;7(11):e48935
pubmed: 23145028
PLoS Comput Biol. 2018 Jan 29;14(1):e1005968
pubmed: 29377902
Transplantation. 2017 Mar;101(3):531-540
pubmed: 27362315
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):3155-60
pubmed: 23382194
Pathogens. 2021 Feb 13;10(2):
pubmed: 33668486
J Am Soc Mass Spectrom. 2016 Nov;27(11):1719-1727
pubmed: 27572102
Signal Transduct Target Ther. 2020 Sep 23;5(1):213
pubmed: 32968059
Herpesviridae. 2010 Dec 07;1(1):2
pubmed: 21429240
Transplantation. 1984 Nov;38(5):465-8
pubmed: 6093296
J Infect Dis. 1986 Mar;153(3):478-88
pubmed: 3005424
J Am Soc Mass Spectrom. 1994 Nov;5(11):976-89
pubmed: 24226387
Chem Biol. 2012 Jun 22;19(6):699-710
pubmed: 22726684
Int J Biochem Cell Biol. 2017 Dec;93:12-24
pubmed: 29061365
Annu Rev Virol. 2016 Sep 29;3(1):333-357
pubmed: 27501258
Hepatology. 1997 Jan;25(1):190-4
pubmed: 8985289
J Gen Virol. 2008 Feb;89(Pt 2):359-368
pubmed: 18198366
Proc Natl Acad Sci U S A. 2010 Feb 9;107(6):2640-5
pubmed: 20133758
J Cell Biol. 2019 Sep 2;218(9):3077-3097
pubmed: 31420453
Int J Proteomics. 2014;2014:147648
pubmed: 24693427
Virology. 2004 Aug 1;325(2):241-51
pubmed: 15246264
Microorganisms. 2020 Apr 06;8(4):
pubmed: 32268565
Elife. 2019 Dec 24;8:
pubmed: 31873071
Nat Rev Drug Discov. 2014 Feb;13(2):123-39
pubmed: 24445563
PLoS Pathog. 2009 Feb;5(2):e1000304
pubmed: 19229316
J Infect Dis. 2006 Jun 1;193(11):1552-6
pubmed: 16652284
Sci Signal. 2010 Aug 03;3(133):ra58
pubmed: 20682912
Am J Transplant. 2017 Apr;17(4):856-879
pubmed: 28117944
Methods Mol Biol. 2014;1119:99-112
pubmed: 24639220
Lancet. 1994 Dec 24-31;344(8939-8940):1737-8
pubmed: 7741857
J Biol Chem. 2001 Jan 12;276(2):1133-7
pubmed: 11050102
Cell Signal. 2008 Aug;20(8):1528-37
pubmed: 18534820
mBio. 2017 Dec 5;8(6):
pubmed: 29208743
J Med Virol. 1997 Mar;51(3):152-8
pubmed: 9139077
Sci Adv. 2022 Oct 28;8(43):eadd1168
pubmed: 36288299
Cancer Res. 2009 Apr 1;69(7):2861-9
pubmed: 19318580
J Virol. 2010 Sep;84(18):9649-54
pubmed: 20610707
BMC Public Health. 2022 Sep 1;22(1):1659
pubmed: 36050659
J Virol. 2004 Aug;78(15):8382-91
pubmed: 15254210
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
PLoS One. 2012;7(11):e50524
pubmed: 23209769
J Cell Commun Signal. 2019 Jun;13(2):179-191
pubmed: 30612298
Sci Rep. 2017 Apr 20;7(1):937
pubmed: 28428537
Cell. 1999 Nov 24;99(5):511-20
pubmed: 10589679
J Biol Chem. 2017 Aug 25;292(34):14080-14091
pubmed: 28655771
J Biol Chem. 2003 Dec 12;278(50):50456-65
pubmed: 14506272
JAMA. 1989 Jun 23-30;261(24):3561-6
pubmed: 2542633
Nat Biotechnol. 2018 Oct;36(9):880-887
pubmed: 30125270
Blood. 2004 Aug 1;104(3):687-95
pubmed: 15090458
mBio. 2019 Aug 20;10(4):
pubmed: 31431555
Curr Opin Cell Biol. 2015 Oct;36:103-12
pubmed: 26363959
Cell Host Microbe. 2010 Sep 16;8(3):284-91
pubmed: 20833379
J Gen Virol. 1996 Dec;77 ( Pt 12):3099-102
pubmed: 9000102
Biochem Biophys Res Commun. 1995 Jun 6;211(1):325-30
pubmed: 7540006
Transplantation. 1990 Jun;49(6):1100-5
pubmed: 2193443
J Virol. 2015 Dec 30;90(6):2959-70
pubmed: 26719258

Auteurs

Samuel Medica (S)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.

Lindsey B Crawford (LB)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.

Michael Denton (M)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.

Chan-Ki Min (CK)

Department of Microbiology & Immunology, Center for Molecular & Tumor Virology, Louisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana, United States of America.

Taylor A Jones (TA)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.

Timothy Alexander (T)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.

Christopher J Parkins (CJ)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.

Nicole L Diggins (NL)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.

Gabriel J Streblow (GJ)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.

Adam T Mayo (AT)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.

Craig N Kreklywich (CN)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.

Patricia Smith (P)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.

Sophia Jeng (S)

Department of Bioinformatics and Computational Biology, Oregon Health and Science University, Portland, Oregon, United States of America.

Shannon McWeeney (S)

Department of Bioinformatics and Computational Biology, Oregon Health and Science University, Portland, Oregon, United States of America.

Meaghan H Hancock (MH)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.

Andrew Yurochko (A)

Department of Microbiology & Immunology, Center for Molecular & Tumor Virology, Louisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana, United States of America.

Michael S Cohen (MS)

Department of Chemical Physiology and Biochemistry, Oregon Health and Science University, Portland, Oregon, United States of America.

Patrizia Caposio (P)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.

Daniel N Streblow (DN)

Vaccine and Gene Therapy Institute, Oregon Health and Science University, Beaverton, Oregon, United States of America.
Division of Pathobiology and Immunology, Oregon National Primate Research Center, Beaverton, Oregon, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH